Cargando…

Atrial Natriuretic Peptide(31–67): A Novel Therapeutic Factor for Cardiovascular Diseases

The characterization of the cardiac hormone atrial natriuretic peptide (ANP(9)(9)(–)(1)(26)), synthesized and secreted predominantly by atrial myocytes under stimulation by mechanical stretch, has established the heart as an endocrine organ with potent natriuretic, diuretic, and vasodilating actions...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Gustavo Jose Justo, Altara, Raffaele, Booz, George W., Cataliotti, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297502/ https://www.ncbi.nlm.nih.gov/pubmed/34305645 http://dx.doi.org/10.3389/fphys.2021.691407

Ejemplares similares

FTIR Analysis of Renal Tissue for the Assessment of Hypertensive Organ Damage and proANP(31–67) Treatment
por: Pioppi, Leonardo, et al.
Publicado: (2023)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

Distorted assessment of left atrial size by echocardiography in patients with increased aortic root diameter
por: Kaplan, Abdullah, et al.
Publicado: (2021)

Editorial: Natriuretic Peptides in Cardiovascular Pathophysiology
por: Volpe, Massimo, et al.
Publicado: (2022)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

Protective Renal Effects of Atrial Natriuretic Peptide: Where Are We Now?
por: Choi, Marcelo Roberto, et al.
Publicado: (2021)

Editorial: Immunomodulatory Approaches in Cardiovascular Diseases
por: Booz, George W., et al.
Publicado: (2022)

In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction
por: Altara, Raffaele, et al.
Publicado: (2018)

Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction
por: Altara, Raffaele, et al.
Publicado: (2017)

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013)

Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis
por: Pandey, Kailash N.
Publicado: (2021)

Effects of cGMP/Akt/GSK-3β signaling pathway on atrial natriuretic peptide secretion in rabbits with rapid atrial pacing
por: Cao, Shuxia, et al.
Publicado: (2022)

Editorial: Cardiac Microvascular Endothelium Contribution to Cardiac Myocyte Growth, Structure, and Contractile Function
por: Altara, Raffaele, et al.
Publicado: (2019)

Central role for BRAF in cardiac hypertrophy: rethinking the pathological–physiological divide
por: Altara, Raffaele, et al.
Publicado: (2023)

Early cardiac-chamber-specific fingerprints in heart failure with preserved ejection fraction detected by FTIR and Raman spectroscopic techniques
por: Tombolesi, Niki, et al.
Publicado: (2022)

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics
por: McKie, Paul M., et al.
Publicado: (2014)

Role of atrial natriuretic peptide in mediating the blood pressure-independent natriuresis elicited by systemic inhibition of nitric oxide
por: Dobrowolski, Leszek, et al.
Publicado: (2014)

STAT3 and Endothelial Cell—Cardiomyocyte Dialog in Cardiac Remodeling
por: Zouein, Fouad A., et al.
Publicado: (2019)

Involvement of the atrial natriuretic peptide in cardiovascular pathophysiology and its relationship with exercise
por: de Almeida, Júlio C, et al.
Publicado: (2012)

Atrial and Brain Natriuretic Peptides- Benefits and Limits of their use in Cardiovascular Diseases
por: Roxana, Mustafa Edme, et al.
Publicado: (2019)

A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era
por: Rubattu, Speranza, et al.
Publicado: (2021)

Toward a New Paradigm for Targeted Natriuretic Peptide Enhancement in Heart Failure
por: Gidlöf, Olof
Publicado: (2021)

Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
por: Idzikowska, Karolina, et al.
Publicado: (2018)

Natriuretic peptides in cardiovascular diseases
por: Piechota, Mariusz, et al.
Publicado: (2008)

Maintaining the Phenotype Stability of Chondrocytes Derived from MSCs by C-Type Natriuretic Peptide
por: Shi, Quan, et al.
Publicado: (2017)

C-type natriuretic peptide (CNP) in the paraventricular nucleus-mediated renal sympatho-inhibition
por: Zheng, Hong, et al.
Publicado: (2023)

Pooled Analysis of Central Venous Pressure and Brain Natriuretic Peptide Levels in Patients With Extubation Failure
por: Cao, Jianghong, et al.
Publicado: (2022)

The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart
por: Altara, Raffaele, et al.
Publicado: (2016)

Role of the Carotid Bodies in the Hypertensive and Natriuretic Responses to NaCl Load in Conscious Rats
por: da Silva, Elaine Fernanda, et al.
Publicado: (2018)

Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Egom, Emmanuel Eroume A.
Publicado: (2021)

Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies
por: Lv, Wenshan, et al.
Publicado: (2018)

Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics
por: Rubattu, Speranza, et al.
Publicado: (2019)

Atrial Natriuretic Peptide and Adiponectin Interactions in Man
por: Birkenfeld, Andreas L., et al.
Publicado: (2012)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

Brain Natriuretic Peptide and Its Biochemical, Analytical, and Clinical Issues in Heart Failure: A Narrative Review
por: Fu, Shihui, et al.
Publicado: (2018)

Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and DOCA-Salt Treatments
por: Cerrudo, Carolina S., et al.
Publicado: (2021)

The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases
por: Rubattu, Speranza, et al.
Publicado: (2018)

NATRIURETIC PEPTIDE SYSTEM AND CARDIOVASCULAR DISEASE
por: Federico, Cacciapuoti
Publicado: (2010)

Cardiovascular Pleiotropic Effects of Natriuretic Peptides
por: Forte, Maurizio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1psn1t73bbpoc17rd408ui4t4u